Edelman, G., Rodon, J., Lager, J., Castell, C., Jiang, J., Van Allen, E. M., . . . Shapiro, G. I. (2018). Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors. Oncologist.
Citación estilo ChicagoEdelman, Gerald, et al. "Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors." Oncologist 2018.
Cita MLAEdelman, Gerald, et al. "Phase I Trial of a Tablet Formulation of Pilaralisib, a Pan‐Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors." Oncologist 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.